Lung squamous cell carcinoma chemotherapy five times, carcinoembryonic antigen increased again, is i

If possible, it is recommended that you have the patient go to the hospital for a detailed examination to see if the carcinoembryonic antigen is elevated because of the metastasis of the tumor.

Hello, there is a possibility of diffusion. It is recommended that you can take Component D to reduce the spread of the virus.

Gastric, colorectal, pancreatic, and gallbladder tumors have a good positive detection rate, and can also be used as an auxiliary diagnostic index for malignant tumors such as lung cancer and breast cancer. Because there can be crossover between benign and malignant diseases, it has a certain effect on its specificity, but benign lesions are generally only temporarily low-increased. It can also be used as a general follow-up indicator for cancer patients.

The specific clinical implications of CEA are:

1. Elevated CEA is mainly seen in colon cancer, rectal cancer, pancreatic cancer, gastric cancer, liver cancer, lung cancer, breast cancer, and other malignant tumors also have varying degrees of positive rates.

2. Continuous follow-up testing can be used for the observation of the efficacy and prognosis after the operation of malignant tumors, and can also be used for the observation of the efficacy of chemotherapy patients. In general, serum CEA concentrations decrease when the condition improves and increase when the disease worsens. For patients with complete surgical resection, CEA generally returns to normal 6 weeks after surgery.

3. Intestinal diverticulum, rectal polyps, colitis, liver cirrhosis, hepatitis and lung diseases (such as emphysema, bronchial asthma) CEA also increased to varying degrees, but the positive rate was low.

of non-smokers cea 5ug l, smokers about 5ug l.

5. Abnormal kidney function can also rise slightly.

In addition, the information you provided "PET-CT has also been done, and no signs of tumor was found", it is not too likely to consider the tumor based on this mild increase in CEA alone (but it cannot be ruled out), and it is recommended that you combine the laboratory tests of other tumor markers (alpha-fetoprotein AFP, cancer antigen 125 (CA125, glycan antigen 19-9 (CA19-9, etc.) and other diseases (such as enteritis, hepatitis, emphysema, bronchial asthma) to make a comprehensive judgment.

In addition, the level of CEA content is affected by the disease and changes, is a reflection of the body's disease of an external indicator, if it is really a very serious disease caused by the increase in CEA content and only rely on what you think of "what drugs and health products can reduce carcinoembryonic antigen index" This approach can not solve the actual problem (just like the severe pain caused by some diseases, taking painkillers can reduce pain and relieve symptoms, but it cannot be a fundamental disease. It's the same as you think.)

nhk:

Maybe. Because it doesn't matter what kind of cancer the patient has. Carcinoembryonic antigen after radiotherapy or chemotherapy.

carcinoembryonic

antigen

or CEA) index. No, 1 is not necessarily **. It is possible that the cancer cells are metastasizing.

It may also be that it doesn't matter. Because of the CEA determination of serum. Although it is to track the cancer**.

Diffusion. and transfers. But only 1 and a half (50%) of the patients** or metastases.

Carcinoembryonic antigen (CAA) index will be elevated. In patients with metastatic lesions.

There are also about 70% of patients. There will be local** at the same time. And metastases organs.

to the liver. Lung. and abdomen-based.

Although CEA is often used to detect asymptomatic tumor markers (tumor

marker)..But. There have also been studies that have said about it before.

Its sensitivity is only about 60%...And the specificity is 80%...If the patient is still worried.

A CT scan can be ordered from your doctor. This is another routine practice to explore local ** lesions. Regardless of the person being examined.

or medical personnel. should have the right idea of CEA. After all.

It is just 1 reference item. Use it to screen for cancer"High-risk groups"...Instead of confirming whether the patient has cancer**.

Carcinoembryonic antigen is not a panacea, it can only indicate the trend, it is best to directly check the primary lesion, check B ultrasound, CT, MR, etc., if it is a gastrointestinal esophageal tumor, you can check the gastroscopic colonoscopy.

Kong's test decoction can make up for the shortcomings of surgery**, radiotherapy and chemotherapy, so as to learn from each other's strengths and enhance the efficacy. Surgery can not remove invisible cancer cells, often cause residual cancer, regional lymph node metastasis, the use of Kong's ** decoction for postoperative consolidation**, can effectively prevent postoperative ** and metastasis; Radiotherapy and chemotherapy have a great effect on the digestive and hematopoietic systems, which can not only significantly reduce the toxic reactions caused by radiotherapy and chemotherapy, but also effectively improve the efficacy of radiotherapy and chemotherapy.

Analysis: Hello, look at the patient you said has lung adenocarcinoma, then now during chemotherapy, although the carcinoembryonic antigen is elevated, it cannot be said that the condition has deteriorated.

Guidance: Sometimes in the recovery period, it doesn't matter if the carcinoembryonic antigen is elevated, now the patient is undergoing chemotherapy, because the chemotherapy is larger, there is great harm to the body, it is recommended that during the chemotherapy period, it can be assisted in the identification of the upper wide section of Chinese medicine to carry out Gong pat bending, so that the attack will also have a very good effect.

Indicates that the tumor has metastasized, or that it has not been perfectly resected.

Carcinoembryonic antigen (CEA) is a low organ-specific tumor marker, which is not limited to a certain type of tumor, and is only significantly elevated in the middle and advanced stages of tumors, so CEA is not helpful for the early detection and differential diagnosis of most tumors. In addition, CEA has a high false positive and false negative, which is not suitable for the diagnosis and screening of a certain malignant tumor, but it is an effective monitoring index for auxiliary diagnosis, prognosis judgment and efficacy observation, and it is also an ideal indicator for detection.

1. For auxiliary diagnosis: when CEA is continuously increased by 5 to 10 times compared with normal, it strongly indicates the existence of malignant tumors, especially intestinal cancer.

2. For prognosis judgment: patients with normal preoperative CEA level have a high surgical rate, and it is not easy to perform postoperatively. Most of those with elevated preoperative CEA have invaded and metastasized, and the prognosis is poor.

3. CEA is an effective monitoring indicator and an ideal indicator for discovery.

CEA can be used to monitor pancreatic, gastric, lung, and breast cancers. If the tumor** is effective, the CEA decreases. Elevated CEA levels often indicate a tumor.

CEA is a cell adhesion molecule that is highly susceptible to infiltration and transfer. Early localized breast cancer patients with CEA should be normal, once elevated, indicating bone or lung metastases. CEA 80 g L, indicating that the tumor has metastasized.

4. CEA is a colon cancer marker, which is currently considered to be the best marker for colon cancer when used in combination with CA242. CEA is an effective surveillance indicator and an ideal indicator for detecting rectal cancer throughout the entire period, with a higher sensitivity than x-ray and proctoscopy.